MMP2 and breast cancer: Previous studies have shown that upon treatment of human BC cells with SFN, on the one hand, SFN dose-dependently downregulates cyclooxygenase-2 (COX2), MMP-2, and MMP-9; on the other hand, SFN induces E-cadherin expression through inhibition of Snail and ZEB1.